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role in the pathogenesis of autoimmune diseases and the patho-
logical consequences of infection. We previously showed that
immunopathologic mechanisms mediated by inflammatory
monocytes underlie the severe focal liver damage induced by
the protozoan parasite, Entamoeba histolytica. Here, we analyze
the contribution of the IL-23/IL-17 axis to the induction and sub-
sequent recovery from parasite-induced liver damage.
Methods: IL-23p19/, IL-17A/F/, CCR2/, and wild-type (WT)
mice were intra-hepatically infected with E. histolytica tropho-
zoites and disease onset and recovery were analyzed by magnetic
resonance imaging. Liver-specific gene and protein expression
during infection was examined by qPCR, microarray, FACS analy-
sis and immunohistochemistry. Immuno-depletion and substitu-
tion experiments were performed in IL-23p19/ and WT mice to
investigate the role of IL-13 in disease outcome.Journal of Hepatology 20
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CCR2/ mice was strongly attenuated compared with that in
WT mice. IL-23p19/ mice showed reduced accumulation of IL-
17 and CCL2 mRNA and proteins. Increased numbers of IL-13-
producing CD11b+Ly6Clo monocytes were associated with disease
attenuation in IL-23p19/mice. Immuno-depletion of IL-13 in IL-
23p19/ mice reversed this attenuation and treatment of
infected WT mice with an IL-13/anti-IL-13-mAb complex sup-
ported liver recovery.
Conclusions: The IL-23/IL-17 axis plays a critical role in the
immunopathology of hepatic amebiasis. IL-13 secreted by
CD11b+Ly6Clo monocytes may be associated with recovery from
liver damage. An IL-13/anti-IL13-mAb complex mimics this func-
tion, suggesting a novel therapeutic option to support tissue heal-
ing after liver damage.
 2016 European Association for the Study of the Liver. Published
by Elsevier B.V. Open access under CC BY-NC-ND license.Introduction
In recent years, significant advances have been made in under-
standing the pivotal role of the interleukin (IL)-23/T helper
(Th)-17 axis in host protection and autoimmunity [1,2]. While
the IL-23/Th17 axis is involved in protection against several patho-
gens [3–5], it is also responsible for immune-mediated diseases,
including autoimmune encephalitis among others [2]. Despite its
role in protection against various pathogens, infection-induced
pathological changes can occur as an adverse side effect after acti-
vation of this pathway [6,7]. Amebic liver abscess (ALA), a severe
form of focal liver destruction caused by the protozoan Entamoeba
histolytica (E. histolytica) might serve as both an example and a
model for studying the relevance of the IL-23/IL-17 axis to the
immunopathology underlying parasite-induced liver damage.
The disease occurs in tropical and subtropical areas throughout16 vol. 64 j 1147–1157
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theworld andmainly affects adultmales [8,9]. Amurinemodel for
ALA shows besides parasite-specific effector molecules, tumor
necrosis factor (TNF) released fromKupffer cells and inflammatory
monocytes contribute to the disease development [10]. The IL-23/
Th17 pathway might be of critical importance in this disease
because it acts upstreamof the cytokines andeffector cells relevant
to liver damage.
The heterodimeric cytokine IL-23 comprises two subunits, a
unique p19 subunit and the p40 subunit [11], and is essential
for Th17 cell differentiation, expansion, and survival [12]. The
IL-23 receptor (IL-23R) complex comprises two subunits, IL-23R
and IL-12Rb1, and is present on a variety of immune cells [13].
IL-23 mediates expansion of IL-17 (IL-17A/F)-expressing T cell
populations [14]. IL-17 and TNF exhibit strong synergy in pro-
moting inflammation [15], and recent studies show that IL-17
is not only involved in the recruitment of neutrophils, but also
in the migration and infiltration of monocytes through induction
of C-C chemokine ligand 2 (CCL2)/monocyte chemoattractant
protein-1 (MCP-1) [16–18]. CCL2 is produced by a variety of cells
in the liver according to the type of injury and stimulus, including
hepatocytes and macrophages [19], hepatic stellate cells [20],
Kupffer cells and endothelial cells [21].
In mice, blood-circulating monocytes express cluster of differ-
entiation molecule 11b (CD11b) and the lymphocyte antigen 6C
(Ly6C), on their surface [22]. Ly6Chi monocytes are referred to as
‘‘classical” or ‘‘proinflammatory” monocytes, and enter inflamed
or injured tissue. In a proinflammatory ‘‘type I” milieu, which is
characterized by increased local concentrations of interferon
(IFN)c andTNF, these cells differentiate intoproinflammatory acti-
vatedmacrophages that express nitric oxide synthase (NOS)2, and
TNF and can initiate immunopathology [22]. The other major
monocyte subset, namely ‘‘non-classical Ly6Clo” or ‘‘regenerative”
monocytes, develop in a ‘‘type 2” milieu (IL-4 and IL-13) and can
further polarize into arginase 1 (Arg1)- and F4/80-expressing
macrophages [23,24]. However, the enormousplasticity anddiver-
sity of monocyte-macrophage-dendritic cell populations will lead
to a new nomenclature in the future [25]. In cases of acute organ
impairment, such as that associated with partial hepatectomy or
toxin-induced liver injury, IL-4/IL-13make a substantial contribu-
tion to liver regeneration [26]; however, in cases of chronic inflam-
mation, IL-13 acts as a pro-fibrotic mediator [27,28].
Here, we examined the role of the IL-23/Th17 axis in a murine
model of parasite-induced liver damage. We observed a signifi-
cant reduction in ALA pathology in IL-23p19/, IL-17A/F/, and
CCR2/ mice, which was accompanied by reduced expression
of corresponding chemokines and cytokines and an increase in
the number of Ly6Clo cells in the livers of IL-23p19/ and
CCR2/ mice immediately post-infection (p.i.); these mice
showed significantly better recovery from liver damage. Liver
regeneration in IL-23p19/ mice was associated with increased
production of IL-13 by CD11b+Ly6Clo monocytes among others.
Depleting IL-13 in IL-23p19/ mice reversed this attenuation.
However, treating wild-type (WT) mice with an IL-13/anti-IL-
13-mAb complex after infection-induced liver injury strongly
supported the healing process.
Materials and methods
Mice
C57BL/6 (WT), IL-17A/F/, and CCR2/ mice were bred and kept under specific
pathogens-free conditions in the animal facility at the Bernhard Nocht Institute1148 Journal of Hepatology 2016for Tropical Medicine, Hamburg, Germany. IL-23p19/ and IL-13 transgenic (IL-
13tg) and respective C57BL/6 control mice were bred in the animal facilities at
the University of Kiel, Germany, and the Research Center Borstel, Germany,
respectively. All mouse strains were backcrossed against the genetic C57BL/6
background for more than 10 generations. Mice were male and aged 8–12 weeks.
Animal experiments were approved by the review board of the State of Hamburg,
Germany, and conducted in accordance with institutional and Animal research:
Reporting of in vivo experiments (ARRIVE) guidelines.
Induction of ALA and monitoring of disease course by magnet resonance imaging
(MRI)
Micewere infected by intrahepatic injection of 1.25  105 in vitro-cultured tropho-
zoites of the highly pathogenic cell line B, generated from E. histolytica trophozoites
(HM-1:IMSS) [29] as described previously [10,30]. For MRI measurements, mice
were pre-anesthetized with a mixture of 1.5% isoflurane/oxygen in a closed box,
placed on a small animal slide (warmed at 37 C), and measured under constant
inhalation of the isoflurane/O2 mixture using a nose mask at a flow rate of
500 ml/min. Abscess course was monitored by MRI using a small animal 7tesla
MRI scanner (Bruker) with a T2-weighted turbo spin echo sequence (T2TSE). OsiriX
Imaging Software DICOM Viewer (Opensource version 32-bit 4.1.1) was used to
measure total abscess volume, calculated by measuring the region of interest
(ROI) in each slice showing the abscess on transversal sections of the abdomen.
qPCR
Total liver RNA was isolated using the RNeasy Mini Kit (Qiagen). cDNA synthesis
was accomplished using Maxima First Strand cDNA Synthesis Kit for RT-qPCR
(Thermo Scientific). qPCR was performed using Maxima SYBR Green qPCR Mas-
ter Mix (Thermo Scientific). Accumulation levels were calculated using the 2DDCt
method [31] and normalized to the housekeeping genes ribosomal protein S9
(RPS9) and glycerinaldehyd-3-phosphate dehydrogenase (GAPDH). Primer
sequences are shown in the Supplementary materials.
Measurement of CCL2 serum levels
The CCL2 concentration in the serum of experimental mice was measured using a
Cytometric-Bead-Array and a Mouse MCP-1 Flex Set (BD).
Flow cytometry analysis of lymphocytes
The followingfluorochrome-labeled antibodies and the corresponding isotype con-
trol antibodies were purchased: B220, CD3, CD4, CD8, CD11b, CD11c, CD90.2,
CD127, F4/80, cd TCR, IL-23R, Ly6C, Ly6G, NK1.1, NKp46, and Siglec-F (BioLegend);
Arg1 (R&D Systems); and IL-13 and IL-17 (eBioscience). Isolation and analysis of
liver and blood lymphocytes is described in the Supplementary materials.
Immunohistology
Paraffin-embedded sections of liver tissue obtained at day 3 p.i. were stained
with hematoxylin and eosin (H&E) and E. histolytica trophozoites were visualized
using pooled polyclonal rabbit sera raised against recombinant E. histolytica anti-
gens. Neutrophils were stained with the 7/4-mAb (Cedarlane), macrophages with
an F4/80-mAb (Serotec), monocytes with a CD11b-mAb (Abcam), proliferation
with a Ki67-mAb (BD), Arg1 with mouse anti-Arginase 1 (BD), and nitric oxide
synthase (NOS) with anti-NOS2 (Abcam) (see Supplementary materials for
methodological details).
Microarray analysis
Total liver RNA was isolated fromWT and IL-23p19/mice at 6 h p.i. as described
above, and RNA integrity checked on an Bioanalyzer 2100 (Agilent). Microarray
analysis was performed using Affymetrix Mouse Gene ST 2.0 arrays and the WT
PLUS Reagent Kit (Affymetrix). Sample amplification, hybridization, washing, and
staining was performed according to the manufacturer’s instructions. Arrays were
scanned on a GeneChip Scanner 3000 7G (see Supplementarymaterials for details).
Immuno-depletion and substitution of IL-17 and IL-13
Depletion of IL-17A (in WT mice) and IL-13 (in IL-23p19/ mice) was performed
by i.p. injection of 100 lg anti-mouse IL-17A and anti-IL-13-mAb (R&D) in 100 ll
PBS 1 day prior to infection. Control WT and IL-23p19/ mice received 100 lgvol. 64 j 1147–1157
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goat IgG control antibody (R&D). The IL-13/anti-IL-13-mAb complex was pre-
pared as follows: recombinant mouse IL-13 (9 lg; BioLegend) and anti-mouse
IL-13-mAb (48 lg; R&D systems) were incubated in 1032 ll PBS for 10 min at
room temperature. Each mouse received 1.2 lg of IL-13 and 6.4 lg of anti-IL-
13-mAb in 150 ll PBS i.p. on days 0, 1, and 2 p.i. [32]. Control animals received
6.4 lg of isotype control goat IgG (R&D systems). IL-13 substitution experiments
were performed by i.p. injection of 100 ll PBS/1.2 lg recombinant IL-13
(BioLegend).
Quantitative and statistical analysis
Mann-Whitney U test or unpaired Student’s t test was used to examine statistical
significant differences between two data sets. The tests were performed by
GraphPad Prism 5.0. A p value of <0.05 was considered statistically significant.
Statistical analysis of the microarray data was performed using an unequal vari-
ance two-sided t test.Results
The IL-23/IL-17 axis promotes immune pathology during parasite-
induced liver damage and affects CD11b+Ly6C+ monocyte
populations
We analyzed the mRNA accumulation of IL-23p19 (IL-23), IL-17,
and CCL2 during the course of ALA development in the liver of
WT and IL-23p19/ mice compared with that in the liver of sham
treated mice. As early as 6 h post intrahepatic infection, the accu-
mulation of IL-23 mRNA in WT mice increased significantly
(Fig. 1A). IL-17 mRNA accumulation in WT mice was highest at
48 h p.i. but was almost undetectable in IL-23p19/ mice
(Fig. 1B). CCL2 mRNA accumulation increased significantly in
WT mice within the first 12 h p.i. No significant increase was
observed in IL-23p19/ mice (Fig. 1C). Serum levels of CCL2 were
significantly lower in IL-23p19/ mice than in WT mice 24 h p.i.
(Fig. 1D). The mRNA levels of the cytokines/chemokines in sham-
operatedWTmice were not higher than those in naïve mice (Sup-
plementary Fig. 1). T2-weighted MRI on Days 3, 5, and 7 p.i.
showed that amebic-induced abscess lesions were smaller in IL-
23p19/ mice than in WT mice (Fig. 1E). Calculation of the
abscess volumes revealed significant smaller abscesses in IL-
23p19/ mice compared to WT mice (Fig. 1F). The decrease in
the size of liver lesions in IL-23p19/ mice was accompanied
by a reduction in the mRNA accumulation of E. histolytica-
specific actin and cysteine peptidase A1 (CPA1) compared with
that in WT mice (48 h p.i.; p <0.011) (Fig. 1G). The gating strategy
used to examine liver infiltrating CD11b+ mononuclear cell pop-
ulations expressing Ly6C and Ly6G is shown in Fig. 1H. While
there were no differences in the recruitment of inflammatory
Ly6Chi monocytes and neutrophil granulocytes between IL-
23p19/ and WT mice, the percentage of Ly6Clo monocytes
was higher in IL-23p19/ mice than in WT mice (Fig. 1I). The fre-
quency of inflammatory Ly6Chi monocytes in the blood of IL-
23p19/ mice before infection was lower than that in WT mice,
and a significant reduction was observed on day 3 p.i. Although
the percentage of Ly6Clo monocytes increased at day 5 p.i., the
percentage of neutrophil granulocytes in IL-23p19/ mice and
WT mice was about the same (Supplementary Fig. 1).
Role and effects of the IL-23/IL-17/CCR2 axis on parasite-induced
liver damage
To further analyze the role of the interaction of IL-23 with IL-17A/
F and CCR2 in liver damage induced by E. histolytica trophozoites,Journal of Hepatology 2016we examined the frequency of liver infiltrating IL-17+ cells and
found that the number of IL-17-producing cells was significantly
lower in the livers of IL-23p19/ mice than in those of WT mice
(Fig. 2A). Hence, we monitored abscess formation in IL-17A/F/
mice and WT mice treated with anti-IL-17A over a period of
7 days p.i. using MRI. The deficiency of IL-17A/F and IL-17A led
to a considerable reduction in the size of abscesses (Fig. 2B). cd
T cells were identified as a major source (approximately 50%) of
IL-17A in WT and IL-23p19/ mice (Fig. 2C), although the fre-
quencies of IL-17A+cdTCR+ cells did not differ between WT and
IL-23p19/ mice during infection (Fig. 2D). Assessment of the
expression of various surface markers showed that NK1.1+ cells
were IL-17A, whereas CD3+, CD8+, cdTCR+ and IL-23R+ cells pro-
duced IL-17A (Fig. 2E).
The reduction in the size of abscesses in IL-17A/F-deficientmice
was associated with a considerable reduction in the mRNA accu-
mulation levels of CCL2 (Fig. 2F), with no effect on the recruitment
of Ly6Chi or Ly6Clo monocytes but a slight decrease in the frequen-
cies of Ly6Chi and Ly6Clo monocytes following IL-17A immune
depletion (Fig. 2G). The frequency of neutrophils was not altered
in IL-17A/F/ mice or in mice depleted of IL-17A compared with
WT mice after infection (data not shown). As previously shown
[10], liver lesions developed after intrahepatic E. histolytica infec-
tion were significantly smaller in CCR2/ mice than in WT mice.
The livers of infected CCR2/ mice showed a lower frequency of
liver-specific Ly6Chi monocytes and a higher frequency of Ly6Clo
monocytes than WT mice (Fig. 2H).
Differences in the infection-related mRNA expression profile between
in WT and IL-23p19/mice
We performed microarray analysis to examine the mRNA expres-
sion profile of WT (n = 3) and IL-23p19/ mice (n = 3) at 6 h fol-
lowing intrahepatic infection.
Two complementary criteria were used. Genes were assumed
to be differentially expressed if they exhibited a p value of 0.01
and a minimal Signal-Log-Ratio (SLR) of ±0.4 or a p value of
0.05 and a SLR of 1.5 (condition 1), or alternatively a p value of
0.05 and a minimal SLR of ±1.5. Based on these criteria, we iden-
tified 1298 genes regulated over time (0 h vs. 6 h p.i.) in the WT
mice and 1333 genes regulated over time (0 h vs. 6 h) in the IL-
23p19/ mice. A total of 81 genes were differentially expressed
between WT and IL-23p19/ mice at 0 h, reflecting a weak prin-
cipal bias attributed to the knockout effect. QIAGEN’s Ingenuity
Pathway Analysis (IPA) software showed overexpression of genes
associated with the development and function of the hematolog-
ical system, cell death and function, cellular movement and
immune cell trafficking, and inflammatory responses in IL-
23p19/ compared to WT mice, whereas genes associated with
tissue and cellular development and lipid metabolism were
mostly downregulated (Fig. 3A). Based on the overall mRNA
expression patterns, we examined the activity of upstream regu-
latory proteins with a specific focus on chemokines and cytokines
that might be relevant to Ly6Clo monocytes and polarization
towards regenerative macrophages. Interestingly, we found
increased activation of toll like receptors (TLRs) and multiple
cytokines (including Th2-type (IL-4, IL-5, IL-13) and Th1-type
(IFN, IL-1, TNF)) in IL-23p19/ compared with WT mice.
Increased expression of growth factors (HGF, IGF, TGF, and Vascu-
lar endothelial growth factor (VEGF)) was observed in both mice,
whereas Th1-type cytokines dominated the early stages p.i. in
WT mice (Supplementary Fig. 2). qPCR of selected chemokinesvol. 64 j 1147–1157 1149
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expressed as the mean ± SEM. p values were determined using the Mann-Whitney U test (⁄p <0.05; ⁄⁄p <0.01; ⁄⁄⁄p <0.001).
Research Articleand cytokines typical for monocyte-dependent tissue repair was
performed using liver-specific mRNA at multiple early time
points p.i. Surprisingly, the levels of mRNA for most C-C chemoki-
nes (CCL3/CCL4/CCL5/CCL8) produced by regenerative mono-1150 Journal of Hepatology 2016cytes/macrophages and relevant to liver regeneration were
lower in the liver of IL-23p19/ mice than in the liver of WT
mice. Moreover, the expression of factors and endothelial recep-
tors involved in the patrolling of Ly6Clo monocytes was eithervol. 64 j 1147–1157
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JOURNAL OF HEPATOLOGYreduced (CX3CL1, CX3CR1) or unaltered (ITGAL, ICAM1 and ICAM2).
Accumulation of Nuclear Receptor Subfamily 4, Group A, Member
1 (Nr4a1) (p <0.05), IL-4, and IL-13 (IL-4: p <0.05; IL-13: p <0.05)
mRNA was significantly upregulated in IL-23p19/ mice com-
pared to WT mice (at 6 h and 12 h) (Fig. 3B).
IL-13-producing cells play a role in liver regeneration in IL-23p19/
mice
Unlike the roleof IL-4 [26,33], the roleof IL-13 in thecontextof liver
tissue regeneration is lesswell understood. Using a gating strategy
based on the increase in mean fluorescence intensity (MFI), IL-13-
producing cells in the livers of infected WT and IL-23p19/ mice
were determined at 12 h p.i. Quantitative analysis revealed that
the MFI of IL-13+ leukocytes and monocytic cells was significantly
higher in infected IL-23p19/ mice than in naïve IL-23p19/
(p <0.05) or infected WT mice (p <0.001) (Fig. 4A and B), and the
MFI of IL-13+ lymphocytic cells was higher in infected
IL-23p19/ mice than in infected WT mice (p <0.01) (Fig. 4C).
The gating strategy described in Fig. 4D was used to identify puta-Journal of Hepatology 2016tive IL-13-producing cells. The MFI of IL-13+CD11b+ and IL-13+-
Ly6Clo monocytic cells was higher in IL-23p19/ mice than in
WT mice. Focusing on IL-13-producing cells, no differences in the
Ly6Chi monocyte subset, Ly6G+ neutrophils, SiglecF+ eosinophils,
CD3+CD4+, and F4/80+ cells were observed between the two mouse
strains (Fig. 4D). ILC2 cells, as putative IL-13 producers, were
detected in low amounts that were also negative for IL-13 (data
not shown). Quantitative analysis revealed an increase in the MFI
of IL-13+CD11b+ cells in IL-23p19/mice comparedwith their naïve
counterparts (p <0.05) or infected WT mice (p <0.001) at 12 h p.i.
(Fig. 4E). TheMFI of IL-13+Ly6Clo monocytes at 12 h p.i. was signifi-
cantly higher in infected IL-23p19/mice than in naïve IL-23p19/
or WT mice, and decreased on day 1 p.i.; however, the MFI of these
cells inWTmice showed a tendency to increase over time (Fig. 4F).
The role of Arg1 and NOS2 during ALA regeneration in IL-23p19/
mice
The accumulation of NOS2 mRNA in WT mice was significantly
upregulated at 12 h p.i. (p <0.01), but did not increase invol. 64 j 1147–1157 1151
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Fig. 3. Definition of biological functional groups and kinetics of selected chemokines/cytokines based on mRNA accumulation in the liver of E. histolytica-infected
WT and IL-23p19/mice. (A) Differentially expressed mRNAs in the liver of WT and IL-23p19/ mice at 6 h p.i. as determined by microarray analysis and categorized into
Ingenuity’s biological functional groups. The selection of biological functions relevant to the phenotype of ALA is highlighted by annotation (n = 3). (B) Kinetics of mRNA
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were determined using the Mann-Whitney U test (⁄p <0.05).
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Fig. 4. Characterization of IL-13 producers by FACS analysis. Gating strategy, histograms and quantitative analysis of liver-specific (A) IL-13+ leukocytes, (B) IL-13+
monocytic cells, and (C) IL-13+ lymphocytic cells in naïve and E. histolytica-infected WT and IL-23p19/ mice relative to the IL-13 isotype control at 12 h p.i. as determined
by mean fluorescence intensity (MFI). (D) Gating strategy and histograms to determine IL-13+CD11b+, IL-13+Ly6Chi, IL-13+Ly6Clo monocytes, IL-13+Ly6G+ neutrophils, IL-
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⁄⁄⁄p <0.001).
JOURNAL OF HEPATOLOGYIL-23p19/ mice; NOS2 mRNA accumulation was significantly
lower at 12 h p.i. in these mice than in WT mice (p <0.01)
(Fig. 5A). Accumulation of Arg1 mRNA increased in both IL-
23p19/ and WT mice as early as 6 h p.i.; a significant upregula-
tion was observed only in IL-23p19/ mice (p <0.01) (Fig. 5B).
However, assessment of the Arg1/NOS2mRNA accumulation ratio
showed a higher Arg1 mRNA expression relative to NOS2 expres-
sion in IL-23p19/ mice than in WT mice (Fig. 5C).
In parallel, the MFI of Ly6CloArg+ cells in infected IL-23p19/
mice increased significantly compared with that in naïve IL-
23p19/ and WT mice (p <0.01) (Fig. 5D). Also, there was a sig-
nificant increase in the MFI of Ly6CloF4/80+ monocytes in infected
mice when compared with naïve IL-23p19/ mice (p <0.01)
(Fig. 5E).
Slices of paraffin-embedded livers of IL-23p19/mice andWT
mice from day 3 p.i. were prepared and stained with H&E andJournal of Hepatology 2016various immunological markers. E. histolytica trophozoites were
visualized using pooled rabbit sera raised against different ame-
bic surface and cellular molecules (see Supplementary materials).
Immunohistological staining of E. histolytica trophozoites
showed mostly intact parasites surrounded by dense immune cell
infiltrates in the abscessed liver in both WT and IL-23p19/ mice
(Fig. 4F). H&E staining revealed an organized structure of the
abscesses consisting of a central area with a dense immune cell
infiltrate (layer 3), a margin consisting of lysed hepatocytes and
sparse immune cell infiltrations (layer 2), and an outer area con-
sisting of unaffected liver tissue (layer 1). Immunohistological
analysis using a mAb against the proliferation marker Ki67 sup-
ported the structural organization of the abscess as determined
by H&E staining (Fig. 5F, upper panel). E. histolytica trophozoites
were surrounded by 7/4+ neutrophils in WT mice, while in IL-
23p19/ mice, the immune cell cluster directly surroundingvol. 64 j 1147–1157 1153
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Fig. 5. NOS2, Arg1 and Ki67 expression in E. histolytica-infected WT and IL-23p19/ mice. WT and IL-23p19/ mice were intra-hepatically infected with E. histolytica
trophozoites. Accumulation of (A) NOS2 and (B) Arg1mRNA in the liver over time. (C) Ratio of Arg1/NOS2mRNA accumulation in IL-23p19/mice compared with that in WT
mice. (D) Increase in the MFI of liver-specific Arg1+Ly6Clo and (E) F4/80+Ly6Clo monocytes. Data represent the mean ± SEM (n = 4-5). (F) Sequential slices of paraffin-
embedded liver sections from WT and IL-23p19/ mice at Day 3 p.i. were stained with a rabbit serum pool against different surface and intracellular E. histolytica
molecules, H&E as well as mAbs against Ki67 (upper detail), neutrophils (7/4), macrophages (F4/80), CD11b, NOS2, and Arg1. A higher magnification of the same liver area is
shown. (G) Quantification of Ki67+ cells from the abscess center (layer 3), abscess margin (layer 2), and adjacent liver tissue (layer 1). Positive cells were manually counted
in representative sections (2–3) from each slide of infected livers from IL-23p19/ (n = 3) and WT (n = 4) mice and analyzed using Image J software. p values were
determined using the unpaired Student’s t test or the Mann-Whitney U test (⁄p <0.05; ⁄⁄p <0.01).
Research Articlethe amebic trophozoites consisted of F4/80+ macrophages (layer
3). By contrast, F4/80+ cells in WT mice were sparsely distributed
around the abscess center (layer 2 and layer 1). Because of the
cross-reactivity of the neutrophil marker 7/4 with CD11b on
inflammatory monocytes and macrophages [34], the sections
were additionally stained with a mAb against CD11b. The results1154 Journal of Hepatology 2016showed that the F4/80+ macrophage population identified in IL-
23p19/ mice was also positive for CD11b, further characterizing
these cells as resident macrophages. In IL-23p19/ mice, the
abscess was surrounded by a margin of CD11b+ cells that were
positive for neither 7/4 nor F4/80, suggesting the presence of
monocytes in this area (layer 1).vol. 64 j 1147–1157
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Fig. 6. Immuno-depletion and reconstitution of IL-13. (A) Schematic showing
the treatment scheme of anti-IL-13-mAb and abscess volumes, as determined by
MRI, in E. histolytica-infected IL-23p19/ and WT mice following administration
of anti-IL-13 or a goat IgG ctrl mAb (100 lg/animal). (B) Schematic showing the
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Staining for NOS2 and Arg1 revealed that NOS2 positivity co-
localized with the distribution of F4/80+ cells in WT mice,
whereas Arg1 positive cells co-localized with hepatocytes within
the healthy tissue area surrounding the abscess. By contrast, in
IL-23p19/ mice, NOS2 positivity localized predominately out-
side of the E. histolytica/immune cell clusters, whereas Arg1+ cells
co-localized with F4/80+ cells within the clusters.
The quantitative analysis of cells positive for the proliferation
marker Ki67 is shown in Fig. 5G. According to the cell layers
shown in Fig. 5F, the abscess center (layer 3) of WT mice had
higher amounts of Ki67+ cells than that of IL-23p19/mice. Com-
parison of Ki67+ cells in layer 2 showed no difference. Although
not significant, there was a clear tendency towards higher
amounts of Ki67 positive cells in IL-23p1/ mice in layer 1, the
region of the liver tissue adjacent to the abscessed area. In IL-
23p19/ mice, significantly more Ki67+ cells were found in the
hepatocytes surrounding the abscess (layer 1) than in the abscess
center (layer 3) (p <0.013).
Effect of IL-13 depletion and substitution or overexpression on
parasite-induced liver damage
To investigate the direct effects of IL-13 on liver tissue repair, we
depleted IL-13 in IL-23p19/ mice, as well as in WT mice, 24 h
prior to intrahepatic E. histolytica infection (Fig. 6A) and moni-
tored abscess development by MRI at the indicated time points.
Immuno-depletion of IL-13 in WT mice resulted in a decrease
in abscess size on day 3 p.i. and an increase on days 5 and 7,
although the difference did not reach statistical significance. In
IL-23p19/ mice, there was a trend towards larger liver lesions
on days 3 and 5 p.i. This effect was significant on day 7 p.i.
(p <0.05) (Fig. 6B). Conversely, liver damage was reduced in
IL-13tg mice, and in WT mice after treatment with recombinant
IL-13, although the difference in the IL-13tg mice was not signif-
icant (Supplementary Fig. 3).
Finally, WT mice treated with an IL-13/anti-IL-13 complex on
the day of infection and on days 1 and 2 p.i. (Fig. 6A) recovered
from liver damage significantly faster throughout the course of
infection.administration of the IL-13/aIL-13 complex in WT mice and abscess volumes in
mice receiving either rIL-13/anti-IL-13 (1.2 lg rIL-13/6.4 lg anti-IL13-mAb/
animal) or goat IgG ctrl mAb (100 lg/animal). Data from two independent
experiments are shown and expressed as the mean ± SEM. p values were
determined using the Mann-Whitney U test (⁄p <0.05; ⁄⁄⁄p <0.001; ⁄⁄⁄⁄p <0.0001).Discussion
The immune response induced by IL-23/IL-17 must be carefully
controlled to avoid immune-mediated pathology. A central medi-
ator in this system is the proinflammatory cytokine IL-17, which
is produced by Th17 cells and by regulatory T cells such as NK T
cells and cd T cells, or by innate immune cells such as innate lym-
phoid cells. IL-23 induces the IL-17 family members IL-17A and
IL-17F in Th17 cells, as well as a unique inflammatory gene signa-
ture that contributes to the pathogenesis of autoimmunity [2].
The IL-23/IL-17 axis is mainly involved in recruiting neutrophils
via the induction of CXCL1, 2 and 5 [35]. However, the induction
of chemokines such as CCL2/MCP-1, CCL3/MIP1a, and CCL20/
LARC via the IL-23/IL-17 axis can lead to recruitment of inflam-
matory monocytes and T cells that can further enhance immune
pathological processes [17]. Thus, protection from pathogens or
immune pathologies that depend on the recruitment of inflam-
matory monocytes is reduced in IL-23p19/ mice [17,36]. IL-
23p19/ mice with experimental glomerulonephritis show
reduced numbers of IL-17-producing Th17 cells, decreasedJournal of Hepatology 2016expression of CCL2, and reduced glomerular monocyte recruit-
ment, and a reduction in the severity of nephritis [36].
IL-23p19/ mice show increased susceptibility to systemic L.
monocytogenes infection, which correlates with the downregula-
tion of CCL2 and a reduction in the number of inflammatory
monocytes that otherwise contribute to controlling this infection
through TNF and NOS2 production [5]. In the model of hepatic
amebiasis presented herein, in which the CCL2-dependent
recruitment of inflammatory monocytes is responsible for liver
damage [10], we focused on the role of IL-23. We observed a sig-
nificant increase in the accumulation of IL-23p19 mRNA and an
increase in the mRNA and protein levels of IL-17 and CCL2. This
suggests a role for the IL-23/IL-17 axis in this model. Hence,
parasite-induced liver damage was markedly reduced in IL-
23p19/ mice in association with the downregulation of IL-17
and CCL2. Consequently, IL-17A/F/ mice, or mice that werevol. 64 j 1147–1157 1155
Research Article
depleted of IL-17A, showed a large reduction in the size of liver
lesions after infection, which correlated with reduced levels of
CCL2 mRNA. Further analysis of the role of monocyte populations
in attenuated liver damage in IL-23p19/ mice showed that the
Ly6Chi monocyte population in the blood of IL-23p19/ mice,
but not that in the liver, decreased. This suggests that CCL3 or
CCL20 compensate for the lack of CCL2 function during the
recruitment of inflammatory monocytes. Alternatively, the atten-
uated liver damage in IL-23p19/ mice might be responsible for
the reduced production of IL-17 and CCL2.
We also observed an early increase in the number of Ly6Clo
monocytes in the liver of infected IL-23p19/ mice. Since there
was no increase in the number of Ly6Clo monocytes in the blood,
we assume that this expanding population arises from Ly6Chi
monocytes and macrophages in the blood and local tissues
[25,37]. This was further supported by the lack of an increase
in the mRNA expression of molecules involved in the recruitment
of Ly6Clo monocytes [23]. Instead, we observed an increase in Th2
cytokines (IL-4 and Il-13) in the livers of IL-23p19/ mice, which
may have contributed to the polarization of Ly6Clo monocytes
into regenerative macrophages [23,24]. The fact that the mRNA
expression of IL-13 and IL-4 was also lower in IL-23p19/ mice
than in WT mice could be explained by the absence of inflamma-
tion and hence the need for lower amounts of these cytokines to
counter regulate an inflammatory process.
We were also interested in identifying the source of IL-13,
since the accumulation of IL-13 mRNA in IL-23p19/ mice
increased as early as 6 h p.i., which seems unusual for a classical
Th2-type immune response based on CD4+Th cells. At 12 h p.i. the
percentage of IL-13+ leukocytes in IL-23p19/ mice was signifi-
cantly higher than that in WT mice and most of these cells were
in the monocyte gate. This led us to identify CD11b+Ly6Clo mono-
cytes as the main IL-13 producers.
Our findings indicated that the CD11b+IL-13+ cell population
also produced Arg1, a well-known marker for macrophages
involved in tissue repair. Together with elevated transcription
of the nuclear receptor Nr4a1 (Nur77) and TLRs such as TLR7,
these data indicate that we have identified further polarization
of these Ly6Clo monocytes towards regenerative macrophages
[38,39].
IL-13 is a pleiotropic cytokine that acts synergistically with IL-
4 to activate alternative pathways leading to the resolution of
inflammation via monocytes/macrophages. However, by induc-
ing tissue transglutaminases, TGFb, collagen, and connective tis-
sue growth factor in hepatic stellate cells, this type of
activation can lead to fibrotic disease processes, as observed in
the lungs of individuals with allergic disorders [27]. Additionally,
the process of tissue repair was associated with a reduction in the
expression of membrane metabolic molecules, whereas we
expected to see increased expression of molecules required for
the accumulation and construction of lipid membranes.
Inhibiting IL-13 reversed the attenuated abscess outcome in
IL-23p19/ mice. Also, reconstitution of IL-13 in WT mice
showed slightly better recovery from liver damage, a phe-
nomenon also observed in IL-13tg mice. Similar trends were
observed for IL-13 and IL-4 in models of hepatectomy and
toxin-induced liver injury. Here, IL-4 and IL-13-dependent activa-
tion of IL-4Ra in hepatocytes led to increased liver regeneration
[26]. In addition, the use of cytokine/mAb complexes is an effec-1156 Journal of Hepatology 2016tive strategy for delivering cytokines as it prolongs their in vivo
availability and stability, especially when cytokine-neutralizing
antibodies are used [40]; hence, treatment of infected WT mice
with an IL-13/anti-IL13-mAb complex led to faster recovery from
liver damage.
In summary, we have identified a crucial role for the IL-23/
IL-17 axis in the immune pathology of ALA. Deficiency of IL-23/
IL-17 and CCL2 results in reduced tissue damage. Amebic-
induced liver damage is strongly reduced in IL-23p19/ mice
and correlates with a reduction in inflammatory, and an
increase in anti-inflammatory, processes. The early tissue repair
in IL-23p19/ mice is initiated by IL-13-producing CD11b+-
Ly6Clo monocytes, which may then develop into tissue-
repairing Arg+F4/80+ macrophages. IL-13 is crucial for liver
regeneration after parasite-induced damage, and a complex of
IL-13/anti-IL-13-mAb has the therapeutic potential to support
healing of liver tissue.Conflict of interest
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